Kintara Presents Updates on Two Phase 2 Clinical Trials at the 2021 American Association for Cancer Research Annual Meeting Apr 12, 2021
Kintara Therapeutics to Participate in Maxim Group's 2021 Emerging Growth Virtual Conference Mar 10, 2021
Kintara Therapeutics Appoints Dr. Mario Lacouture to Scientific Advisory Board for Cutaneous Metastatic Breast Cancer Mar 3, 2021
Kintara Therapeutics Enrolls Final Patient in Phase 2 Clinical Trial of VAL-083 for Recurrent GBM Feb 17, 2021
Kintara Therapeutics Announces Fiscal Second Quarter 2021 Financial Results and Provides Corporate Update Feb 12, 2021
Henry Ford Cancer Institute is First in the World to Activate Two New Treatments in GBM AGILE Trial for Glioblastoma Brain Cancer Feb 3, 2021
Kintara Announces Initiation of Patient Recruitment for VAL-083's Study Arm in the GBM AGILE Trial Jan 13, 2021
